Susi Roger E.'s Form 4 filing
Iradimed Corp (IRMD) · filed Nov 4, 2025
- Accession no.
- 0001613801-25-000026
- Filed
- Nov 4, 2025
- Trade date
- Nov 3, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $413.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Susi Roger E.CIK 0001613801 | Director, Officer (CEO, PRESIDENT, CHAIRMAN), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | Common Stock | SSaleDisposed | −446 | $79.82F2 | −$35,599.72 | 2,327,054 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −601 | $81.28F3 | −$48,849.28 | 2,326,453 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −900 | $81.71F4 | −$73,539 | 2,325,553 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −1,335 | $83.22F5 | −$111,098.7 | 2,324,218 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −1,618 | $83.85F6 | −$135,669.3 | 2,322,600 | Indirect | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −100 | $84.60 | −$8,460 | 2,322,500 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $79.50 to $80.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $80.61 to $81.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $81.50 to $81.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $82.58 to $83.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $83.52 to $84.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.